ArticleCommunications medicine2025

Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride.

Yuen-Ting Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.